Romiplostim Injection: As a Promising Therapy
Created 1 month ago by marykudro

Romiplostim falls under the class of medicines named thrombopoietin receptor agonists. This medication acts by causing the cells in the bone marrow to develop more platelets. The romiplostim injection is used to increase the level or number of platelets (cells that help the blood to clot) in order to fade the probability of bleeding in adult recipients who have immune thrombocytopenia (ITP; idiopathic thrombocytopenic purpura; an ongoing condition that may be responsible for causing easy bruising or bleeding due to abnormally reduced platelet in the blood). The standard dosage of Romiplostim injection should be administered once weekly as a subcutaneous injection.